Physician

Abdulfatah Osman, M.D.

According to 2025 Medicare claims, Abdulfatah Osman, M.D. (NPI: 1609844141) practices cardiology in the Flint, MI market, with the plurality of this provider's patient population coming from Genesee, MI. This provider's primary affiliated billing organization is GENESYS PRACTICE PARTNERS INC (NPI: 1790433803; TIN: 030516871) and primary practice location at 48439-8395. Osman is affiliated with the Genesys PHO, L.L.C. (ACO ID: A2597), participating under the MSSP model.

Osman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 760 traditional Medicare patients, billed 2,020 HCPCS/CPT codes, and received $152,937 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 1,400 prescription claims across 396 beneficiaries totaling $411,590 in drug costs, led by Eliquis (Apixaban). 2020 DME data shows 24 claims. Open Payments data shows 7 records totaling $402. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $145,598 and ending at $152,937. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $61,991 to $411,590. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	766	2,004	$145,598
2016	739	1,850	$134,319
2017	775	1,825	$130,115
2018	626	1,443	$103,606
2019	633	1,535	$117,442
2020	574	1,365	$100,408
2021	635	1,501	$121,356
2022	710	1,679	$132,575
2023	786	2,132	$179,340
2024	760	2,020	$152,937

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	208	819	$61,991
2016	219	794	$56,004
2017	225	749	$123,540
2018	247	932	$135,108
2019	235	890	$109,348
2020	258	754	$131,260
2021	224	687	$118,356
2022	256	758	$110,216
2023	345	1,070	$520,106
2024	396	1,400	$411,590

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	59	$2,204
2016	N/R	24	$1,345
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	24	$833
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	62	62	$181
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	281	344	$82
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	240	243	$73
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	268	302	$10
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	65	71	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	161	8,760	$159,132
Entresto	Sacubitril/Valsartan	26	1,320	$27,748
Jardiance	Empagliflozin	38	1,380	$26,196
Repatha Sureclick	Evolocumab	15	420	$8,178
Brilinta	Ticagrelor	11	390	$5,494

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$402	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abdulfatah Osman, M.D.?

Tedicare shows public-source Medicare data for Abdulfatah Osman, M.D. (NPI 1609844141), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdulfatah Osman, M.D. have ACO affiliation data?

Abdulfatah Osman, M.D. is shown with ACO affiliation data for Genesys PHO, L.L.C. (MSSP, ACO ID A2597).

What billing organization is linked to Abdulfatah Osman, M.D.?

Abdulfatah Osman, M.D. is linked to GENESYS PRACTICE PARTNERS INC (billing NPI 1790433803) in the available physician profile data.

Does Abdulfatah Osman, M.D. have Open Payments data?

Abdulfatah Osman, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.